| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.01 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.29 | 0.03 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |